TP53 and lung cancer: As our previous data suggested that Bok-deficient lung cancer cells have a defect in DNA repair leading to a p53-dependent arrest in G2 (Figs. 2 and S3), we wanted to determine if Bok-deficient cells are thus more sensitive to DNA damaging agents.